Pharmacy Residency Faculty - For Health Professionals - Children's Hospital of The King's Daughters Health System

Home > For Health Professionals > Pharmacy Residency Faculty

Text Size:

| | |

Pharmacy Practice Faculty at CHKD

Click their name to see profile information.

James Dice, Pharm.D.

Background

Pharmacy School
Doctor of Pharmacy - University of Tennessee Health Science Center College of Pharmacy
Bachelor of Science in Pharmacy - Philadelphia College of Pharmacy and Science
Residency
ASHP Accredited Residency in Hospital Pharmacy Medical College of Virginia Hospitals

Pediatric Post-Pharm.D LeBonheur Children’s Medical Center University of Tennessee Health Science Center

Clinical Interests

Honors and Awards

Three Lexi-Comp/PPAG Best Practice Awards, Pediatric Pharmacy Advocacy Group (2006, 2008, & 2010)
Fellow Pediatric Pharmacy Advocacy Group (FPPAG)
2012 Richard A. Helms Award of Excellence in Pediatric Pharmacy Practice

Professional Affiliations

Pediatric Pharmacy Advocacy Group (PPAG) – Board of Directors, Executive Vice President, Chief of Operations Officer, Chairman of the Board
MedImmune Advisory Committee (Care of the High Risk Neonate)
Paddock’s Pediatric Compounding Pharmacy Advisory Board (Charter Member)

Selected Publications

Dice JE, Bhatia J. Patient Ductus Arteriosus: An Overview. Journal of Pediatrics Pharmacology and Therapeutics 2007; 12: 138-146.
Dice JE. Physical Compatibility of Alprostadil with Commonly Used IV Solutions and Medications in the NICU. Journal of Pediatric Pharmacology and Therapeutics 2006; 11: 233-36.
Storms LE, Chicella MF, Toolan ER, Restaino I, Dice J. Sevelamer Use in Pediatric End Stage Renal Disease: A Case Report. Journal of Pediatric Pharmacology and Therapeutics 2004; 9: 145.
Chicella MF, Batres LA, Heesters MS, Dice JE. Prokinetic Drug Therapy in Children: A Review of Current Options. The Annals of Pharmacotherapy 2005; 39: 706-711.
Dice J ed. Handbook on Extemporaneous Formulations, American Society of Hospital Pharmacists, Bethesda, Maryland, 1987.

Michael Chicella, Pharm.D.

Clinical Assistant Professor of Pediatrics, Eastern Virginia Medical School

Background

Pharmacy School
Doctor of Pharmacy Campbell University School of Pharmacy
Bachelor of Science in Pharmacy - University of North Carolina School of Pharmacy
Residency
Pediatric Pharmacotherapy Specialty Residency LeBonheur Children’s Medical Center University of Tennessee Health Science Center

Clinical Interests

Honors and Awards

Two Lexi-Comp/PPAG Best Practice Awards, Pediatric Pharmacy Advocacy Group (2008 & 2010)
Faculty Member of the Year Award, Auburn University School of Pharmacy
Ross Award for Outstanding Effort in Pediatric Research

Professional Affiliations

Selected Publications

Chicella MF, Krueger KP. Prospective Randomized Double-Blind Placebo Controlled Trial of Recombinant Human Erythropoietin Administration to Reduce Blood Transfusions in Anemic Pediatric Intensive Care Patients. Journal of Pediatric Pharmacology and Therapeutics 2006; 11: 101-106.
Storms LE, Chicella MF, Dice J. Sevelamer Therapy in Pediatric End-Stage Renal Disease. Pharmacotherapy 2006; 26: 410-413.
Chicella M, Partibhan A, Jansen P, Marlowe KF, Bencsath AF, Krueger K, Boerth R. Propylene Glycol Accumulation Associated with Continuous Infusion Lorazepam in Pediatric Intensive Care Patients. Critical Care Medicine 2002; 30: 2752-2756.
Hovinga C, Chicella M, Rose DF, Eades SK, Dalton J, Phelps SJ. Use of Intravenous Valproic Acid in Three Pediatric Patients with Nonconvulsive or Convulsive Status Epilepticus. Annals of Pharmacotherapy 1999; 33: 579-584.